As per DelveInsight’s assessment, The neurovascular devices market is mainly propelled by the growing incidence of neurological conditions such as stroke, cerebral aneurysms, arteriovenous malformations, and other cerebrovascular disorders. The increasing occurrence of both ischemic and hemorrhagic strokes particularly among the aging population and individuals with risk factors like hypertension and diabetes is significantly raising the demand for advanced neurovascular intervention technologies. Furthermore, greater awareness regarding early disease detection, continuous advancements in minimally invasive treatment techniques, and improvements in healthcare infrastructure are collectively supporting the wider adoption of neurovascular devices across hospitals and specialized neurology centers.

DelveInsight’s “Neurovascular Devices Market Insights, Competitive Landscape, and Market Forecast – 2034” report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Neurovascular Devices companies actively working in the market.

Explore the future of healthcare innovation with our comprehensive Neurovascular Devices Market Forecast. Stay ahead in the industry!

https://www.delveinsight.com/report-store/neurovascular-devices-interventional-neurology-market

Neurovascular Devices Overview

Neurovascular Devices are specialized medical tools used to diagnose, treat, and manage disorders of the brain’s blood vessels, such as aneurysms, strokes, and arteriovenous malformations. These devices include stents, coils, catheters, embolic protection devices, and flow diverters that help restore proper blood flow, prevent clot formation, or repair vessel abnormalities. Neurovascular devices play a critical role in minimally invasive procedures, allowing physicians to treat complex cerebrovascular conditions with greater precision and reduced risk compared to traditional surgery, ultimately improving patient outcomes and recovery times.

Neurovascular Devices Market Insights

The neurovascular devices market is largely driven by the growing prevalence of neurological conditions, including stroke, cerebral aneurysms, arteriovenous malformations, and other cerebrovascular disorders. The rising number of ischemic and hemorrhagic stroke cases especially among the aging population and individuals with risk factors such as hypertension and diabetes has significantly increased the need for advanced neurovascular intervention devices. Furthermore, increasing awareness regarding early detection, ongoing progress in minimally invasive treatment techniques, and the expansion of healthcare infrastructure are contributing to the wider adoption of neurovascular devices across hospitals and specialized neurology centers.

DelveInsight Analysis: The global neurovascular devices market size is projected to grow at a CAGR of 8.40% from 2026 to 2034, with the market size expected to rise from USD 3,904.74 million in 2025 to USD 8,044.66 million by 2034, indicating strong and sustained growth during the forecast period.

To know more about why North America is leading the market growth in the Neurovascular Devices market, get a snapshot of the report Neurovascular Devices Market Trends

Recent Developments in the Neurovascular Devices Market Report

• In May 2025, Terumo Interventional Systems announced the commercial launch of its FDA-approved ROADSAVER™ Carotid Stent System. Developed to be used alongside the Nanoparasol® Embolic Protection System, the ROADSAVER stent is designed for the treatment of carotid artery stenosis, particularly in patients who face a higher risk of complications from carotid endarterectomy procedures.

• In March 2025, Boston Scientific introduced an updated FilterWire EZ embolic protection system in selected European markets. The device incorporates a guidewire with a 110-micron pore filter at its tip, designed to trap embolic debris while allowing continuous blood flow and ensuring reliable conformity with the arterial walls.

• In September 2024, The Minima Stent System received FDA clearance for its stent device intended for the treatment of intracranial aneurysms, providing patients with a minimally invasive therapeutic option.

• In June 2024, Penumbra announced the CE Mark approval and European launch of BMX™81 and BMX™96, advanced neuro access technologies designed for the management of both ischemic and hemorrhagic strokes. These devices represent some of Penumbra’s most innovative solutions to date, highlighting the company’s focus on technological advancement and improved clinical outcomes within the neurovascular devices market.

Key Players in the Neurovascular Devices Market

Some of the key market players operating in the Neurovascular Devices market include- Johnson & Johnson Services Inc., Medtronic, Stryker, Terumo Corporation, Penumbra, Inc., Microport Scientific Corporation, Kaneka Corporation, Integer Holdings Corporation, phenox GmbH, Perflow Medical Ltd., Balt, Rapid Medical, ASAHI INTECC CO., LTD., Acandis GmbH, Cerus Endovascular Inc., and others.

To read more about the latest highlights related to Neurovascular Devices, get a snapshot of the key highlights entailed in the Neurovascular Devices Market Forecast Report

Market Analysis on the Neurovascular Devices Market

According to estimates, North America is projected to hold the largest share—around 38%—of the neurovascular devices market in 2025 compared to other regions. This dominance is attributed to the high incidence of stroke and other neurovascular conditions, along with a well-developed healthcare infrastructure and widespread adoption of advanced minimally invasive technologies. Favorable reimbursement frameworks also support market growth in the region. Moreover, the strong presence of leading medical device manufacturers, ongoing investments in research and development, and increasing awareness initiatives focused on stroke prevention and treatment further reinforce North America’s leading position in the market.

The competitive landscape of the neurovascular devices market is relatively consolidated, with a few major global companies controlling a significant portion of the market, while regional manufacturers and emerging startups are gradually expanding their presence. Leading neurovascular device companies such as Medtronic, Stryker Corporation, Johnson & Johnson, Penumbra Inc., and Terumo Corporation hold strong positions through extensive product portfolios that include neurovascular stents, coils, thrombectomy devices, and embolization systems. Their dominance is supported by advanced technologies and well-established global distribution networks.

These market leaders continue to strengthen their foothold through ongoing innovation in minimally invasive treatment approaches, the integration of advanced imaging and navigation technologies, and strategic mergers and acquisitions. For instance, Stryker’s acquisition of Inari Medical reflects efforts to broaden its neurovascular product portfolio and expand its capabilities in the evolving neurovascular intervention space.

Scope of the Neurovascular Devices Market Report

• Coverage: Global

• Study Period: 2023–2034

• Neurovascular Devices Market Segmentation By Product Type: Cerebral Embolization and Aneurysm Coiling Devices [Embolic Coils, Flow Diversion Devices, and Liquid Embolic Agents], Cerebral Balloon Angioplasty and Stenting Systems [Carotid Artery Stents and Embolic Protection Systems], Neurothrombectomy Devices [Clot Retrievers, Suction Devices, and Vascular Snare], and Support Devices [Micro Catheters and Micro Guidewires]

• Neurovascular Devices Market Segmentation By Application: Stroke, Cerebral Aneurysm, Carotid Artery Stenosis, and Others

• Neurovascular Devices Market Segmentation By End User: Hospitals, Ambulatory Surgical Centers, and others

• Neurovascular Devices Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World

• Key Neurovascular Devices Companies: Johnson & Johnson Services Inc., Medtronic, Stryker, Terumo Corporation, Penumbra, Inc., Microport Scientific Corporation, Kaneka Corporation, Integer Holdings Corporation, phenox GmbH, Perflow Medical Ltd., Balt, Rapid Medical, ASAHI INTECC CO., LTD., Acandis GmbH, Cerus Endovascular Inc., and others

• Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View

Which MedTech key players in the Neurovascular Devices market are set to emerge as the trendsetter explore @ Neurovascular Devices Manufacturer

Table of Contents

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/